Literature DB >> 1675133

Chronic paranoid psychosis after misuse of MDMA.

A R Winstock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1675133      PMCID： PMC1669834          DOI： 10.1136/bmj.302.6785.1150-b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Chronic paranoid psychosis after misuse of MDMA ("ecstasy")

Authors:  P McGuire; T Fahy
Journal:  BMJ       Date:  1991-03-23

2.  MDMA. The dark side of ecstasy.

Authors:  G N Hayner; H McKinney
Journal:  J Psychoactive Drugs       Date:  1986 Oct-Dec

Review 3.  Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

Authors:  D J McKenna; S J Peroutka
Journal:  J Neurochem       Date:  1990-01       Impact factor: 5.372
  4 in total
  8 in total

1.  Ecstasy and the dance of death.

Authors:  J A Henry
Journal:  BMJ       Date:  1992-07-04

2.  Fatal poisoning by MDMA (ecstasy) and MDEA: a case report.

Authors:  V Fineschi; A Masti
Journal:  Int J Legal Med       Date:  1996       Impact factor: 2.686

3.  Ecstasy and neurodegeneration. Advice is that "less is more".

Authors:  J Merrill
Journal:  BMJ       Date:  1996-08-17

4.  Reckless behaviour related to the use of 3,4-methylenedioxymethamphetamine (ecstasy): apropos of a fatal accident during car-surfing.

Authors:  P J Hooft; H P van de Voorde
Journal:  Int J Legal Med       Date:  1994       Impact factor: 2.686

Review 5.  Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

Authors:  A R Green; A J Cross; G M Goodwin
Journal:  Psychopharmacology (Berl)       Date:  1995-06       Impact factor: 4.530

6.  Persistent nigrostriatal dopaminergic abnormalities in ex-users of MDMA ('Ecstasy'): an 18F-dopa PET study.

Authors:  Yen F Tai; Rosa Hoshi; Catherine M Brignell; Lisa Cohen; David J Brooks; H Valerie Curran; Paola Piccini
Journal:  Neuropsychopharmacology       Date:  2010-12-15       Impact factor: 7.853

7.  Understanding the Global Problem of Drug Addiction is a Challenge for IDARS Scientists.

Authors:  S F Ali; E S Onaivi; P R Dodd; J L Cadet; S Schenk; M J Kuhar; G F Koob
Journal:  Curr Neuropharmacol       Date:  2011-03       Impact factor: 7.363

8.  Symptomatological features of patients with and without Ecstasy use during their first psychotic episode.

Authors:  Fabio Rugani; Silvia Bacciardi; Luca Rovai; Matteo Pacini; Angelo Giovanni Icro Maremmani; Joseph Deltito; Liliana Dell'osso; Icro Maremmani
Journal:  Int J Environ Res Public Health       Date:  2012-06-27       Impact factor: 3.390
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.